USA Financial Formulas’s Ingevity NGVT Stock Holding History

USA Financial Formulas’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-5,629	Closed	-$415K	–	353
2018 Q2	$415K	Sell	5,629 -29	-0.5%	-$2.31K	0.1%	167
2018 Q1	$417K	Buy	+5,658	New	+$423K	0.1%	167

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

USA Financial Formulas's NGVT Position: Q3 2018 in Review

USA Financial Formulas sold out of Ingevity (NGVT) in Q3 2018, closing a stake of 5,629 shares — an estimated $415K sold.

USA Financial Formulas first reported a position in NGVT in Q1 2018 and held it in 2 quarters. The position peaked at $417K in Q1 2018. 328 funds tracked by Wall St. Rank hold NGVT as of Q3 2018.

USA Financial Formulas reported no remaining Ingevity position as of Q3 2018 after selling out during the quarter.
USA Financial Formulas sold 5,629 Ingevity shares in Q3 2018, an estimated $415K.
USA Financial Formulas first reported a position in Ingevity in Q1 2018 and held it in 2 quarters.
USA Financial Formulas's Ingevity position peaked at $417K in Q1 2018.
328 funds tracked by Wall St. Rank held Ingevity as of Q3 2018.

Based on USA Financial Formulas's 13F filing for Q3 2018, filed 31 Oct 2018.